Why Third-Party Lab Reports Matter

Any supplier can claim quality. A third-party certificate of analysis (COA) is the difference between a claim and evidence: the sample was sent to an independent laboratory that has no stake in the sale, and the results were generated there, not in the supplier's own facility. In an industry where quality can vary dramatically between suppliers and even between batches from the same supplier, third-party testing provides an objective, unbiased assessment of product quality that is essential for researchers who need reliable, reproducible results.

The first section of a COA identifies the sample: product name, lot number, and analysis date. Match these against the label on your vial — the lot number should correspond to the batch you actually received. This is a critical but often overlooked step in verifying product quality, as it ensures that the certificate you are reviewing actually corresponds to the material in your vial. If the lot number on the certificate does not match the lot number on your vial, the certificate may be for a different batch and may not accurately reflect the quality of the material you received. Reputable suppliers will always provide certificates that match the specific lot number of the product shipped, and they will make these certificates easily accessible, either through their website or upon request.

The second section is the purity result, typically an HPLC-UV chromatogram with a peak list. Look for the main peak's area percentage; a figure above 99% is the standard for high-purity research peptides. The accompanying MS report confirms identity by comparing the expected and measured monoisotopic masses. The purity result is perhaps the most important number on the certificate, as it tells you what fraction of the sample is actually the target peptide versus impurities such as deletion sequences, truncated peptides, oxidation products, or residual reagents. For most research applications, a purity of 95% or higher is acceptable, but for sensitive assays or in vivo studies, purity of 98% or higher may be required. It is important to note that purity is not the same as potency — a peptide can be highly pure but have low biological activity if it has been denatured or if the sequence is incorrect, which is why identity confirmation by mass spectrometry is equally important.

Finally, check the details: the analytical method, the performing laboratory, and the analyst's signature or identification. A certificate that names a real, contactable laboratory is far more meaningful than one that omits the source. At amideworks we publish batch certificates on each product page and provide them on request for every lot. The analytical method used for purity testing should be specified, as different methods can produce different results. Reversed-phase HPLC with UV detection at 214 nm is the industry standard for peptide purity testing, and certificates that use this method are generally more reliable than those that use less common or less well-validated methods. The performing laboratory should be clearly identified, with contact information available so that you can verify the authenticity of the certificate if necessary. Some suppliers may use in-house testing, which can be reliable but lacks the objectivity of independent third-party testing. Whenever possible, look for suppliers that use independent, accredited laboratories for their quality control testing.

The value of third-party testing extends beyond just the individual certificate — it also speaks to the supplier's commitment to quality and transparency. A supplier that invests in independent third-party testing for every batch is demonstrating that they have confidence in their products and are willing to subject them to objective scrutiny. This is in contrast to suppliers that rely solely on in-house testing or that provide generic certificates that are not specific to individual batches. Third-party testing also provides a check against errors or inconsistencies in the supplier's own quality control processes, as the independent laboratory will use its own methods and standards to evaluate the product. This redundancy is particularly important in the peptide industry, where synthesis errors, contamination, or degradation can occur at any stage of the production process, from synthesis to purification to lyophilization to storage.

One of the most important reasons to insist on third-party testing is the problem of counterfeit or adulterated products in the peptide market. While most reputable suppliers are honest about their products, there are unscrupulous suppliers that may sell mislabeled, contaminated, or even completely fake products. In some cases, suppliers have been found to sell peptides that are significantly less pure than advertised, or that contain no active peptide at all. Third-party testing provides a defense against these practices, as the independent laboratory will objectively measure the purity and identity of the product, regardless of what the supplier claims. If a supplier is unwilling or unable to provide third-party test results for their products, this should be viewed as a red flag, and researchers should consider whether the potential cost savings are worth the risk of using low-quality or counterfeit material.

Another important consideration is the reproducibility of research results. In recent years, the scientific community has become increasingly concerned about the reproducibility crisis, with many studies failing to be replicated by other researchers. While there are many factors contributing to this crisis, the quality of research reagents is one that is often overlooked. Using peptides of inconsistent or unknown quality can lead to variable results that are difficult to reproduce, as the actual dose of active peptide may differ between experiments or between laboratories. By using peptides that have been thoroughly characterized by third-party testing, researchers can ensure that they are using consistent, well-defined material, which is a prerequisite for reproducible research. This is particularly important for multi-site studies or for studies that will be used as the basis for future research, as inconsistent reagent quality can confound the results and make it difficult to draw meaningful conclusions.

When reviewing a third-party certificate, there are several common issues to watch for that may indicate potential problems with the product or the certificate itself. One red flag is a certificate that is generic rather than lot-specific — that is, a certificate that does not include a lot number or that uses the same lot number for multiple products. Another red flag is a certificate that only provides a purity number without showing the actual chromatogram or mass spectrum, as this makes it impossible to verify the results or to identify potential issues such as co-eluting peaks. A third red flag is a certificate from an unknown or unverifiable laboratory, particularly one that has no website or contact information. Finally, be wary of certificates that show purity levels that seem too good to be true — while high purity is desirable, purity levels above 99.5% are relatively uncommon for synthetic peptides, and certificates that consistently show such high levels may be suspect.

It is also important to understand the limitations of third-party testing. While a COA provides valuable information about the purity and identity of a peptide, it does not provide a complete characterization of the product. For example, a standard COA typically does not include information about endotoxin levels, sterility, biological activity, or long-term stability. These factors may be important for certain applications, particularly in vivo studies or cell culture experiments, and they may require additional testing beyond what is included on a standard certificate. Reputable suppliers will often offer additional testing services for an additional fee, or they may be able to provide guidance on whether additional testing is necessary for your specific application. It is also important to recognize that a COA represents a snapshot of the product at the time of testing — the quality of the peptide may change over time due to degradation, particularly if it is not stored properly. For this reason, it is important to follow the supplier's storage recommendations and to use the peptide within its stated shelf life.

The process of third-party testing typically involves several steps. First, the supplier sends a sample from each batch to the independent laboratory, along with documentation specifying the product name, sequence, and expected molecular weight. The laboratory then performs the requested tests, typically including HPLC for purity and MS for identity, using its own validated methods and standards. The results are compiled into a certificate of analysis, which includes the test methods, the results, the date of testing, and the signature or identification of the analyst who performed the testing. The certificate is then returned to the supplier, who makes it available to customers. The entire process typically takes several days to a week, which is why some suppliers may not have certificates available immediately for new products or for products that have just been released. However, the delay is well worth it for the assurance of independent, objective quality testing.

In summary, third-party laboratory reports are an essential tool for evaluating peptide quality, providing an objective, unbiased assessment that goes beyond the supplier's own claims. A proper COA includes lot-specific information (product name, lot number, analysis date), purity results from HPLC with a chromatogram, identity confirmation from mass spectrometry, and details about the analytical method and performing laboratory. By carefully reviewing these details and ensuring that the certificate matches the specific lot of product received, researchers can verify that they are using high-quality, well-characterized material that will produce reliable, reproducible results. While third-party testing is not a complete guarantee of quality — it does not measure biological activity, sterility, or long-term stability — it is the single most important factor in evaluating peptide quality and should be a prerequisite for any purchasing decision. At amideworks, we are committed to transparency and quality, and we provide third-party batch certificates for every product, making them easily accessible on our website and upon request.

Dr. James Mitchell, Ph.D.

Research Scientist · Biochemical Engineering

Dr. Mitchell has over 15 years of experience in peptide synthesis and analytical chemistry. He received his Ph.D. in Biochemical Engineering from MIT and has published over 40 peer-reviewed papers on peptide therapeutics and drug delivery systems.